McNeil Matthew B, Ryburn Heath W, Tirados Justin, Cheung Chen-Yi, Cook Gregory M
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.
iScience. 2021 Dec 4;25(1):103573. doi: 10.1016/j.isci.2021.103573. eCollection 2022 Jan 21.
remains a leading cause of infectious disease morbidity and mortality for which new drug combination therapies are needed. Combinations of respiratory inhibitors can have synergistic or synthetic lethal interactions with sterilizing activity, suggesting that regimens with multiple bioenergetic inhibitors could shorten treatment times. However, realizing this potential requires an understanding of which combinations of respiratory complexes, when inhibited, have the strongest consequences on bacterial growth and viability. Here we have used multiplex CRISPR interference (CRISPRi) and as a physiological and molecular model for mycobacterial respiration to identify interactions between respiratory complexes. In this study, we identified synthetic lethal and synergistic interactions between respiratory complexes and demonstrated how the engineering of CRISPRi-guide sequences can be used to further explore networks of interacting gene pairs. These results provide fundamental insights into the functions of and interactions between bioenergetic complexes and the utility of CRISPRi in designing drug combinations.
仍然是需要新的联合药物疗法的传染病发病和死亡的主要原因。呼吸抑制剂的组合可与杀菌活性产生协同或合成致死相互作用,这表明使用多种生物能量抑制剂的治疗方案可能会缩短治疗时间。然而,要实现这一潜力,需要了解呼吸复合体的哪些组合在受到抑制时对细菌生长和生存能力具有最强烈的影响。在这里,我们使用多重CRISPR干扰(CRISPRi)并将其作为分枝杆菌呼吸的生理和分子模型,以确定呼吸复合体之间的相互作用。在这项研究中,我们确定了呼吸复合体之间的合成致死和协同相互作用,并展示了如何利用CRISPRi引导序列的工程设计来进一步探索相互作用基因对的网络。这些结果为生物能量复合体的功能和相互作用以及CRISPRi在设计药物组合中的效用提供了基本见解。